Creo Medical Group PLC (CREO)
Industry Medical Devices
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
13.25p
Buy
13.75p
0.00p (+0.00%)
Prices updated at 23 Jun 2026, 16:23 BST
| Prices minimum 15 mins delay
Prices in GBX
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kevin Timothy Crofton
CEO
Mr. Craig Jonathan Gulliford
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
104
Head office
Beaufort Park Way
Chepstow
United Kingdom
NP16 5UH
Key personnel
Owner name | Salary |
|---|---|
Mr. Kevin Timothy Crofton Non-Executive Director, Chairman | - |
Ms. Ivonne Maria Gloria Cantu Non-Executive Director | - |
Mr. Richard John Rees Executive Director, Chief Financial Officer and Company Secretary | - |
Mr. Craig Jonathan Gulliford Executive Director, Chief Executive Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| M&G Investment Management Limited | 51,233,836 |
| M&G Recovery Fund | 51,233,836 |
| River Global Investors LLP | 25,356,346 |
| RGI UK Opportunities Fund | 25,356,346 |
| RGI Fund Management Limited | 24,440,568 |
Director dealings
Date | Action |
|---|---|
| 28 May 2026 | Purchase |
| 28 May 2026 | Purchase |
| 28 May 2026 | Purchase |
| 13 Jan 2026 | Purchase |
| 13 Jan 2026 | Transfer in |
| 13 Jan 2026 | Transfer in |
| 13 Jan 2026 | Purchase |
| 08 Aug 2025 | Transfer out |
| 08 Aug 2025 | Transfer out |
| 08 Aug 2025 | Transfer out |
| 22 Jul 2025 | Purchase |
| 22 Jul 2025 | Purchase |
Please note that past performance is not a reliable indicator of future returns.